Other functions. Bacterial translocation and liver cancer incidence in the risk evaluation of viral load elevation and associated liver disease/cancer study (reveal). 8/25/18 - 8/24/19.

Ended Purchase Order Awarded Last action

Contract number
75N91018P00597
Awardee
Awarding agency
Obligated
$21,125

Award facts

Opportunity
Contract value 100% obligated
$21,125.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30303, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Georgia State University for $21,125.00 on August 25, 2018, for bacterial translocation and liver cancer incidence research under the REVEAL study, with performance in Atlanta, Georgia. The order carries a firm fixed price and runs through August 24, 2019. No set-aside was used.

Quick answers

Who was awarded contract 75N91018P00597?

75N91018P00597 was awarded to Georgia State University by National Cancer Institute (National Institutes of Health) on August 25, 2018.

How much is contract 75N91018P00597 worth?

The government has obligated $21,125 on 75N91018P00597.

Was contract 75N91018P00597 competed?

The extent of competition for 75N91018P00597 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award